Latest News

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

3140 of 115015
Newswise: Mount Sinai Receives $1 Million Grant for Prostate Cancer Research

Mount Sinai Receives $1 Million Grant for Prostate Cancer Research

Mount Sinai Health System

The Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai has received a $1 million grant from The Arthur M. Blank Family Foundation.

Channels: All Journal News, Cancer, Healthcare, In the Workplace, Men's Health, Grant Funded News,

Released:
5-Dec-2019 10:15 AM EST
Open in New Tab
Comment
Newswise: International Society of Gastrointestinal Oncology Appoints Weijing Sun, MD, President-Elect

International Society of Gastrointestinal Oncology Appoints Weijing Sun, MD, President-Elect

University of Kansas Cancer Center

The International Society of Gastrointestinal Oncology (ISGIO), a not-for-profit global educational organization committed to GI oncology, announces that Weijing Sun, MD, FACP, has been elected the society’s next leader.

Channels: Digestive Disorders,

Released:
5-Dec-2019 9:40 AM EST
Open in New Tab
Comment
Announcement
New HPI trademark logo.jpg

Radiologist Success in MIPS APM Pathway

Harvey L. Neiman Health Policy Institute

CMS has implemented a quality payment incentive program, referred to as the Quality Payment Program, which rewards value and outcomes for clinicians participating in Medicare in one of two ways: Merit-based incentive Payment System (MIPS) and Advanced Alternative Payment Models (APMs).

Channels: All Journal News, Healthcare,

Released:
5-Dec-2019 9:15 AM EST
Open in New Tab
Comment
Announcement
coriell_logo_CMYK.jpg

Coriell Institute for Medical Research Scientist Receives Grant to Find Drivers of Breast Cancer

Coriell Institute for Medical Research

Shoghag Panjarian, PhD, a research scientist at the Coriell Institute for Medical Research, has been awarded a grant from the W. W. Smith Charitable Trust to support her search for epigenetic factors that contribute to the development and growth of breast cancer.

Channels: All Journal News, Cancer, In the Workplace, Women's Health,

Released:
5-Dec-2019 9:00 AM EST
Open in New Tab
Comment
Research Alert
Newswise: Likelihood of Prenatal Screening for Blood Disorders Varies Between Type of Healthcare Provider

Likelihood of Prenatal Screening for Blood Disorders Varies Between Type of Healthcare Provider

Rutgers Cancer Institute of New Jersey

A Rutgers Cancer Institute of New Jersey investigator and other collaborators examined prenatal screening practices for blood disorders between different types of care providers and found different variations in prenatal guidance.

Channels: Blood, Cancer, OBGYN, Women's Health, Medical Meetings,

Released:
5-Dec-2019 9:00 AM EST
Open in New Tab
Comment
Announcement
Embargo will expire:
6-Dec-2019 1:00 AM EST
Released to reporters:
5-Dec-2019 9:00 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 6-Dec-2019 1:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Research Results
Embargo will expire:
9-Dec-2019 12:05 AM EST
Released to reporters:
5-Dec-2019 9:00 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 9-Dec-2019 12:05 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Feature
Newswise: Addition of Post-Transplant Chemotherapy to Standard Immune Treatment Shows Increase of Allogeneic Transplant Patients in Remission

Addition of Post-Transplant Chemotherapy to Standard Immune Treatment Shows Increase of Allogeneic Transplant Patients in Remission

Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey investigators compared outcomes for allogeneic stem cell transplant patients when post-transplant cyclophosphamide (PCy) was added as part of standard treatment than if standard treatment was given alone. Results showed an increase in the number of patients who were free of disease and off immunosuppression at one-year in the PCy cohort.

Channels: Cancer, Immunology, Surgery, Transplantation, Medical Meetings,

Released:
5-Dec-2019 8:45 AM EST
Open in New Tab
Comment
Research Results
Newswise: What Does DNA’s Repair Shop Look Like? New Research Identifies the Tools

What Does DNA’s Repair Shop Look Like? New Research Identifies the Tools

New York University

A team of scientists has identified how damaged DNA molecules are repaired inside the human genome, a discovery that offers new insights into how the body works to ensure its health and how it responds to diseases that stem from impaired DNA.

Channels: All Journal News, Cancer, Cell Biology, Genetics, Stem Cells, National Institutes of Health (NIH), Artificial Intelligence, Grant Funded News,

Released:
5-Dec-2019 8:40 AM EST
Open in New Tab
Comment
Research Results

Showing results

3140 of 115015

Chat now!
1.37319